Free Trial

Danaher Co. (NYSE:DHR) Shares Sold by United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund

Danaher logo with Multi-Sector Conglomerates background

United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund decreased its holdings in Danaher Co. (NYSE:DHR - Free Report) by 22.8% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 116,176 shares of the conglomerate's stock after selling 34,360 shares during the period. United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund's holdings in Danaher were worth $32,299,000 at the end of the most recent quarter.

A number of other institutional investors have also recently made changes to their positions in DHR. CarsonAllaria Wealth Management Ltd. bought a new stake in Danaher in the second quarter worth about $25,000. nVerses Capital LLC purchased a new position in shares of Danaher during the second quarter worth approximately $25,000. MFA Wealth Advisors LLC purchased a new position in shares of Danaher during the second quarter worth approximately $51,000. Financial Connections Group Inc. purchased a new position in shares of Danaher during the second quarter worth approximately $51,000. Finally, Western Pacific Wealth Management LP purchased a new position in shares of Danaher during the first quarter worth approximately $55,000. Institutional investors own 79.05% of the company's stock.

Insider Transactions at Danaher

In related news, SVP Georgeann Couchara sold 952 shares of the company's stock in a transaction dated Monday, August 26th. The shares were sold at an average price of $268.37, for a total transaction of $255,488.24. Following the completion of the sale, the senior vice president now owns 4,212 shares of the company's stock, valued at approximately $1,130,374.44. This represents a 18.44 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 11.10% of the company's stock.

Analysts Set New Price Targets

Several equities analysts recently issued reports on the stock. Barclays cut their price objective on shares of Danaher from $285.00 to $275.00 and set an "equal weight" rating on the stock in a report on Wednesday, October 23rd. TD Cowen lifted their price objective on shares of Danaher from $310.00 to $315.00 and gave the company a "buy" rating in a report on Wednesday, October 23rd. Robert W. Baird cut their price objective on shares of Danaher from $278.00 to $277.00 and set an "outperform" rating on the stock in a report on Wednesday, October 23rd. Stifel Nicolaus lifted their price target on shares of Danaher from $250.00 to $265.00 and gave the stock a "hold" rating in a report on Wednesday, October 23rd. Finally, StockNews.com raised shares of Danaher from a "hold" rating to a "buy" rating in a report on Wednesday, November 6th. Five investment analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company. According to data from MarketBeat, Danaher presently has a consensus rating of "Moderate Buy" and an average price target of $287.16.

Get Our Latest Report on Danaher

Danaher Stock Performance

NYSE DHR traded down $2.08 on Thursday, reaching $239.45. 3,152,855 shares of the company's stock traded hands, compared to its average volume of 2,747,775. The stock has a 50 day moving average price of $263.42 and a 200-day moving average price of $260.64. The firm has a market cap of $172.95 billion, a price-to-earnings ratio of 46.08, a P/E/G ratio of 4.40 and a beta of 0.85. Danaher Co. has a fifty-two week low of $204.15 and a fifty-two week high of $281.70. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.01 and a current ratio of 1.37.

Danaher (NYSE:DHR - Get Free Report) last issued its quarterly earnings data on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share for the quarter, topping analysts' consensus estimates of $1.57 by $0.14. The business had revenue of $5.80 billion during the quarter, compared to the consensus estimate of $5.59 billion. Danaher had a net margin of 16.39% and a return on equity of 10.62%. The company's revenue was up 3.1% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $2.02 earnings per share. Equities research analysts predict that Danaher Co. will post 7.51 EPS for the current fiscal year.

Danaher Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, October 25th. Stockholders of record on Friday, September 27th were paid a dividend of $0.27 per share. The ex-dividend date was Friday, September 27th. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.45%. Danaher's dividend payout ratio is currently 20.61%.

Danaher Company Profile

(Free Report)

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

See Also

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Should you invest $1,000 in Danaher right now?

Before you consider Danaher, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Danaher wasn't on the list.

While Danaher currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

NVIDIA Earnings: Can Blackwell Propel the Stock to $200+ in 2025?

NVIDIA Earnings: Can Blackwell Propel the Stock to $200+ in 2025?

NVIDIA's Q3 earnings exceeded expectations with 95% revenue growth and 111% EPS growth. Could $200+ be the next target for NVIDIA stock in 2025?

Related Videos

’Best Report in 2 Years’: NVIDIA Earnings Crushes Expectations Again
How to Profit from NVIDIA’s Earnings: Short-Term Trading Guide
NVIDIA Nears All-Time Highs: How High Can This AI Leader Climb?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines